Home Compare ABT vs TMO
Stock Comparison · Single-driver result

Abbott Laboratories vs Thermo Fisher Scientific: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Thermo Fisher Scientific carrying a narrow edge on growth. Abbott Laboratories still has the edge on stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The comparison is mainly decided in growth, with the rest of the profile carrying less weight.

Trajectory Similarity
0.75
Similar
Peer-set rank: #8
within Abbott Laboratories's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.

The match is driven mainly by revenue growth trajectory and margin consistency.

Similarity drivers
revenue growth trajectorymargin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
ABT
Abbott Laboratories
53
Peer-Score
Signal qualityHigh
vs
TMO
Thermo Fisher Scientific Inc.
54
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: ABT vs TMO Profitability 59 50 Stability 80 62 Valuation 66 65 Growth 0 35 ABT TMO
Gap Ranking
#1 Growth +35
#2 Stability +18
#3 Profitability +9
#4 Valuation +1
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ABT and TMO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ABTTMO Relative valuation Structural strength

The setup stays mixed because structure and the price setup do not align cleanly in one direction.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Both sit in the weaker half on growth, with Thermo Fisher Scientific Inc. still coming out ahead.
Stability
Both rank well on stability, but Abbott Laboratories still holds a clear edge.
Growth — Dominant Gap
ABT
0
TMO
35
Gap+35in favour of TMO

Earnings growth is one contributing factor within the growth lead.

What keeps the gap from being one-sided

Stability still leans toward Abbott Laboratories, so the lead is real without reading as one-way.

What this means for the comparison

The main read on growth is clearer than the broader score gap.

Explore full peer positioning in AssetNext

Break down the ABT vs TMO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-driven comparisons

Explore how ABT and TMO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.